These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 19538689)

  • 21. Lithium and its neuroprotective and neurotrophic effects: potential treatment for post-ischemic stroke sequelae.
    Gold AB; Herrmann N; Lanctôt KL
    Curr Drug Targets; 2011 Feb; 12(2):243-55. PubMed ID: 20863277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new avenue for lithium: intervention in traumatic brain injury.
    Leeds PR; Yu F; Wang Z; Chiu CT; Zhang Y; Leng Y; Linares GR; Chuang DM
    ACS Chem Neurosci; 2014 Jun; 5(6):422-33. PubMed ID: 24697257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring lithium's transcriptional mechanisms of action in bipolar disorder: a multi-step study.
    Akkouh IA; Skrede S; Holmgren A; Ersland KM; Hansson L; Bahrami S; Andreassen OA; Steen VM; Djurovic S; Hughes T
    Neuropsychopharmacology; 2020 May; 45(6):947-955. PubMed ID: 31652432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular actions and clinical pharmacogenetics of lithium therapy.
    Can A; Schulze TG; Gould TD
    Pharmacol Biochem Behav; 2014 Aug; 123():3-16. PubMed ID: 24534415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lithium Use During Pregnancy in a Patient With Bipolar Disorder and Multiple Sclerosis.
    Lorettu L; Carpita B; Nivoli A; Milia P; De Iorio G; Cremone IM; DellʼOsso L
    Clin Neuropharmacol; 2020; 43(5):158-161. PubMed ID: 32947427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential mechanisms of action of lithium in bipolar disorder. Current understanding.
    Malhi GS; Tanious M; Das P; Coulston CM; Berk M
    CNS Drugs; 2013 Feb; 27(2):135-53. PubMed ID: 23371914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes.
    de Sousa RT; Streck EL; Zanetti MV; Ferreira GK; Diniz BS; Brunoni AR; Busatto GF; Gattaz WF; Machado-Vieira R
    Psychopharmacology (Berl); 2015 Jan; 232(1):245-50. PubMed ID: 24961563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lithium - past, present, future.
    Rybakowski JK
    Int J Psychiatry Clin Pract; 2020 Nov; 24(4):330-340. PubMed ID: 33169645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders.
    Chiu CT; Chuang DM
    Pharmacol Ther; 2010 Nov; 128(2):281-304. PubMed ID: 20705090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A kinesin signaling complex mediates the ability of GSK-3beta to affect mood-associated behaviors.
    Du J; Wei Y; Liu L; Wang Y; Khairova R; Blumenthal R; Tragon T; Hunsberger JG; Machado-Vieira R; Drevets W; Wang YT; Manji HK
    Proc Natl Acad Sci U S A; 2010 Jun; 107(25):11573-8. PubMed ID: 20534517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The lithium ion: a foundation for psychopharmacological specificity.
    Soares JC; Gershon S
    Neuropsychopharmacology; 1998 Sep; 19(3):167-82. PubMed ID: 9653704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with lithium efficacy in bipolar disorder.
    Rybakowski JK
    Harv Rev Psychiatry; 2014; 22(6):353-7. PubMed ID: 25377609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lithium for older adults with bipolar disorder: Should it still be considered a first-line agent?
    Shulman KI
    Drugs Aging; 2010 Aug; 27(8):607-15. PubMed ID: 20658789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lithium increases platelet serine-9 phosphorylated GSK-3β levels in drug-free bipolar disorder during depressive episodes.
    de Sousa RT; Zanetti MV; Talib LL; Serpa MH; Chaim TM; Carvalho AF; Brunoni AR; Busatto GF; Gattaz WF; Machado-Vieira R
    J Psychiatr Res; 2015 Mar; 62():78-83. PubMed ID: 25691093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
    Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
    Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.
    Rybakowski JK
    CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A critical appraisal of lithium's efficacy and effectiveness: the last 60 years.
    Grof P; Müller-Oerlinghausen B
    Bipolar Disord; 2009 Jun; 11 Suppl 2():10-9. PubMed ID: 19538682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic Mechanisms of Lithium in Bipolar Disorder: Recent Advances and Current Understanding.
    Malhi GS; Outhred T
    CNS Drugs; 2016 Oct; 30(10):931-49. PubMed ID: 27638546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton magnetic resonance spectroscopy changes after lithium treatment. Systematic review.
    Szulc A; Wiedlocha M; Waszkiewicz N; Galińska-Skok B; Marcinowicz P; Gierus J; Mosiolek A
    Psychiatry Res Neuroimaging; 2018 Mar; 273():1-8. PubMed ID: 29414126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is There Justification to Treat Neurodegenerative Disorders by Repurposing Drugs? The Case of Alzheimer's Disease, Lithium, and Autophagy.
    Damri O; Shemesh N; Agam G
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.